Amendment: SEC Form SC 13D/A filed by BlackRock Municipal Income Fund Inc.
BLACKROCK MUNICIPAL INCOME FUND, INC.
|
(Name of Issuer)
|
VARIABLE RATE DEMAND PREFERRED SHARES
|
(Title of Class of Securities)
|
09262J201
|
(CUSIP Number)
|
Bank of America Corporation
Bank of America Corporate Center
100 N. Tryon Street
Charlotte, North Carolina 28255
|
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
April 26, 2022
|
(Date of Event which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Bank of America Corporation
56-0906609
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☒
|
||
|
|
||||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
||||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0%
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
HC
|
|
|
|||
|
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Banc of America Preferred Funding Corporation
75-2939570
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a)
|
☐
|
||
(b)
|
☒
|
||||
|
|
||||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
||
WC
|
|
|
|||
|
|
||||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)
|
|
☐
|
||
|
|
|
|||
|
|
||||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
7
|
SOLE VOTING POWER
|
|
|
|
0
|
|
|
|||
|
|
||||
8
|
SHARED VOTING POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
9
|
SOLE DISPOSITIVE POWER
|
|
|
||
0
|
|
|
|||
|
|
||||
10
|
SHARED DISPOSITIVE POWER
|
|
|
||
0 |
|
|
|||
|
|
||||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
0
|
|
|
|||
|
|
||||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
☐
|
||
|
|
|
|||
|
|
||||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
||
0%
|
|
|
|||
|
|
||||
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
CO
|
|
|
|||
|
|
Item 2. |
Identity and Background
|
Item 5. |
Interest in Securities of the Issuer
|
Item 7. |
Material to be Filed as Exhibits
|
Exhibit No.
|
Description
|
|
Joint Filing Agreement, dated as of December 13, 2024, by and among the Reporting Persons.
|
BANK OF AMERICA CORPORATION
|
||
By:
|
/s/ Andres Ortiz
|
|
Name: Andres Ortiz
|
||
Title: Authorized Signatory
|
||
BANC OF AMERICA PREFERRED FUNDING CORPORATION
|
||
By:
|
/s/ Andres Ortiz
|
|
Name: Andres Ortiz
|
||
Title: Authorized Signatory
|
Name
|
Position with Bank of
America Corporation
|
Principal Occupation
|
||
Brian T. Moynihan
|
Chairman of the Board, Chief Executive Officer and Director
|
Chairman of the Board and Chief Executive Officer of Bank of America Corporation
|
||
Paul M. Donofrio
|
Vice Chair
|
Vice Chair of Bank of America Corporation
|
||
Thong M. Nguyen
|
Vice Chair, Head of Global Strategy & Enterprise Platforms
|
Vice Chair, Head of Global Strategy & Enterprise Platforms of Bank of America Corporation
|
||
Bruce R. Thompson
|
Vice Chair, Head of Enterprise Credit
|
Vice Chair, Head of Enterprise Credit of Bank of America Corporation
|
||
Dean C. Athanasia
|
President, Regional Banking
|
President, Regional Banking of Bank of America Corporation
|
||
James P. DeMare
|
President, Global Markets
|
President, Global Markets of Bank of America Corporation
|
||
Kathleen A. Knox
|
President, The Private Bank
|
President, The Private Bank of Bank of America Corporation
|
||
Matthew M. Koder
|
President, Global Corporate and Investment Banking
|
President, Global Corporate and Investment Banking of Bank of America Corporation
|
||
Bernard A. Mensah
|
President, International; CEO, Merrill Lynch International
|
President, International of Bank of America Corporation and CEO, Merrill Lynch International
|
||
Lindsay DeNardo Hans
|
President, Co-Head Merrill Wealth Management
|
President, Co-Head Merrill Wealth Management of Bank of America Corporation
|
||
Eric Schimpf
|
President, Co-Head Merrill Wealth Management
|
President, Co-Head Merrill Wealth Management of Bank of America Corporation
|
||
Aditya Bhasin
|
Chief Technology and Information Officer
|
Chief Technology and Information Officer of Bank of America Corporation
|
||
D. Steve Boland
|
Chief Administrative Officer
|
Chief Administrative Officer of Bank of America Corporation
|
||
Alastair Borthwick
|
Chief Financial Officer
|
Chief Financial Officer of Bank of America Corporation
|
Sheri Bronstein
|
Chief Human Resources Officer
|
Chief Human Resources Officer of Bank of America Corporation
|
||
Geoffrey Greener
|
Chief Risk Officer
|
Chief Risk Officer of Bank of America Corporation
|
||
Thomas M. Scrivener
|
Chief Operations Executive
|
Chief Operations Executive of Bank of America Corporation
|
||
Lauren A. Mogensen
|
Global General Counsel
|
Global General Counsel of Bank of America Corporation
|
||
Lionel L. Nowell, III
|
Lead Independent Director
|
Lead Independent Director, Bank of America Corporation; Former Senior Vice President and Treasurer, PepsiCo, Inc.
|
||
Sharon L. Allen
|
Director
|
Former Chairman, Deloitte LLP
|
||
Jose E. Almeida
|
Director
|
Chairman, President and Chief Executive Officer of Baxter International Inc.
|
||
Pierre J.P. de Weck1
|
Director
|
Former Chairman and Global Head of Private Wealth Management, Deutsche Bank AG
|
||
Arnold W. Donald
|
Director
|
Former President and Chief Executive Officer, Carnival Corporation & Carnival plc
|
||
Linda P. Hudson
|
Director
|
Former Executive Officer, The Cardea Group, LLC and Former President and Chief Executive Officer of BAE Systems, Inc.
|
||
Monica C. Lozano
|
Director
|
Lead Independent Director, Target Corporation; Former Chief Executive Officer, Former College Futures Foundation and Former Chairman, US Hispanic Media Inc.
|
||
Denise L. Ramos
|
Director
|
Former Chief Executive Officer and President of ITT Inc.
|
||
Clayton S. Rose
|
Director
|
Baker Foundation Professor of Management Practice at Harvard Business School
|
||
Michael D. White
|
Director
|
Former Chairman, President, and Chief Executive Officer of DIRECTV
|
||
Thomas D. Woods2
|
Director
|
Former Vice Chairman and Senior Executive Vice President of Canadian Imperial Bank of Commerce; Former Chairman, Hydro One Limited
|
||
Maria T. Zuber
|
Director
|
Vice President for Research and E.A., Griswold Professor of Geophysics, MIT
|
Name
|
Position with Banc of
America Preferred Funding
Corporation
|
Principal Occupation
|
||
John J. Lawlor
|
Director and President
|
Managing Director, Municipal Markets and Public Sector Banking Executive of BofA Securities, Inc. and Bank of America, National Association
|
||
James Duffy
|
Managing Director
|
Director; MBAM BFO, The CFO Group
of Bank of America, National Association
|
||
Michael I. Jentis
|
Managing Director
|
Managing Director, Head of Sales – Public Finance of BofA Securities, Inc. and Bank of America, National Association
|
||
Mona Payton
|
Managing Director
|
Managing Director, Municipal Markets Executive for Short-Term Trading of BofA Securities, Inc. and Bank of America, National Association
|
||
Edward J. Sisk
|
Director and Managing Director
|
Managing Director, Public Finance Executive of BofA Securities, Inc. and Bank of America, National Association
|
||
John B. Sprung
|
Director
|
Corporate Director
|
||
David A. Stephens
|
Director and Managing Director
|
Managing Director, Executive for Public Finance and Public Sector Credit Products of BofA Securities, Inc. and Bank of America, National Association
|
TRADE DATE
|
BUY/SELL
|
QUANTITY
|
PRICE
|
EXECUTION | ||||||||
04/26/2022
|
B
|
400
|
$
|
12.17
|
OTC
|
|||||||
04/26/2022
|
B
|
100
|
$
|
12.17
|
OTC
|
|||||||
04/26/2022
|
B
|
75
|
$
|
12.18
|
OTC
|
|||||||
04/26/2022
|
S
|
75
|
$
|
12.18
|
BATS X
|
|||||||
04/26/2022
|
S
|
100
|
$
|
12.17
|
NYSE
|
|||||||
04/26/2022
|
S
|
400
|
$
|
12.17
|
NYSE
|
|||||||
04/28/2022
|
B
|
270
|
$
|
12.3106
|
OTC
|
|||||||
04/29/2022
|
S
|
270
|
$
|
12.2793
|
OTC
|
|||||||
06/16/2022
|
S
|
1,239
|
$
|
11.4734
|
OTC
|
|||||||
06/17/2022
|
B
|
808
|
$
|
11.51
|
OTC
|
|||||||
06/17/2022
|
B
|
431
|
$
|
11.51
|
OTC
|
|||||||
07/08/2022
|
B
|
4,075
|
$
|
12.2012
|
OTC
|
|||||||
07/11/2022
|
S
|
300
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
348
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.32
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.3
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.3
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.3
|
OTC
|
|||||||
07/11/2022
|
S
|
99
|
$
|
12.31
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.3
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.29
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.28
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.28
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.27
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.28
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.27
|
OTC
|
|||||||
07/11/2022
|
S
|
328
|
$
|
12.27
|
OTC
|
|||||||
07/11/2022
|
S
|
100
|
$
|
12.28
|
OTC
|
|||||||
07/11/2022
|
S
|
200
|
$
|
12.27
|
OTC
|
|||||||
08/29/2022
|
B
|
700
|
$
|
12.0965
|
OTC
|
|||||||
08/29/2022
|
S
|
100
|
$
|
11.9701
|
OTC
|
|||||||
08/29/2022
|
S
|
100
|
$
|
11.98
|
OTC
|
|||||||
08/29/2022
|
S
|
200
|
$
|
11.9701
|
OTC
|
|||||||
08/29/2022
|
S
|
100
|
$
|
11.98
|
OTC
|
|||||||
08/29/2022
|
S
|
200
|
$
|
11.9701
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
25
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
20
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
49
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
44
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
1,400
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
97
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
38
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
800
|
$
|
11.66
|
OTC
|
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
300
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
B
|
827
|
$
|
11.65
|
OTC
|
|||||||
09/13/2022
|
S
|
827
|
$
|
11.65
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
20
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
97
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
38
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
44
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
300
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
800
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
49
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
25
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
100
|
$
|
11.66
|
OTC
|
|||||||
09/13/2022
|
S
|
1,400
|
$
|
11.66
|
OTC
|
|||||||
10/20/2022
|
B
|
36
|
$
|
10.7822
|
OTC
|
|||||||
10/24/2022
|
S
|
36
|
$
|
10.5642
|
OTC
|
|||||||
10/28/2022
|
B
|
600
|
$
|
10.4
|
OTC
|
|||||||
10/31/2022
|
S
|
500
|
$
|
10.37
|
OTC
|
|||||||
10/31/2022
|
S
|
100
|
$
|
10.374
|
OTC
|
|||||||
12/20/2022
|
B
|
1,500
|
$
|
11.245
|
OTC
|
|||||||
01/04/2023
|
S
|
1,500
|
$
|
11.495
|
OTC
|
|||||||
01/12/2023
|
B
|
100
|
$
|
11.65
|
OTC
|
|||||||
01/12/2023
|
B
|
100
|
$
|
11.65
|
OTC
|
|||||||
01/12/2023
|
B
|
38
|
$
|
11.65
|
OTC
|
|||||||
01/12/2023
|
B
|
600
|
$
|
11.65
|
OTC
|
|||||||
01/12/2023
|
B
|
100
|
$
|
11.66
|
OTC
|
|||||||
01/12/2023
|
S
|
600
|
$
|
11.65
|
OTC INTERNAL
|
|||||||
01/12/2023
|
S
|
100
|
$
|
11.65
|
NYSE
|
|||||||
01/12/2023
|
S
|
100
|
$
|
11.66
|
NYSE
|
|||||||
01/12/2023
|
S
|
100
|
$
|
11.65
|
NYSE
|
|||||||
01/12/2023
|
S
|
38
|
$
|
11.65
|
NYSE
|
|||||||
01/17/2023
|
B
|
3,366
|
$
|
11.7973
|
OTC
|
|||||||
01/18/2023
|
S
|
3,357
|
$
|
11.8873
|
OTC
|
|||||||
01/19/2023
|
S
|
9
|
$
|
11.8294
|
OTC
|
|||||||
03/28/2023
|
B
|
200
|
$
|
11.43
|
OTC
|
|||||||
03/28/2023
|
S
|
200
|
$
|
11.43
|
OTC INTERNAL
|
|||||||
05/12/2023
|
S
|
10
|
$
|
11.5008
|
OTC
|
|||||||
05/15/2023
|
B
|
10
|
$
|
11.4783
|
OTC
|
|||||||
05/17/2023
|
B
|
4,500
|
$
|
11.445
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
200
|
$
|
11.44
|
OTC
|
05/17/2023
|
S
|
92
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
8
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
92
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
8
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
57
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
43
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.43
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.42
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.42
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.43
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
95
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
5
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
05/17/2023
|
S
|
100
|
$
|
11.44
|
OTC
|
|||||||
06/05/2023
|
B
|
291
|
$
|
11.26
|
OTC
|
|||||||
06/05/2023
|
S
|
72
|
$
|
11.27
|
MEMX
|
|||||||
06/05/2023
|
S
|
26
|
$
|
11.275
|
OTC
|
|||||||
06/05/2023
|
S
|
47
|
$
|
11.275
|
OTC
|
|||||||
06/05/2023
|
S
|
73
|
$
|
11.285
|
NASDAQ
|
|||||||
06/05/2023
|
S
|
30
|
$
|
11.295
|
NASDAQ
|
|||||||
06/05/2023
|
S
|
43
|
$
|
11.295
|
NASDAQ
|
|||||||
06/07/2023
|
B
|
100
|
$
|
11.32
|
OTC
|
|||||||
06/07/2023
|
B
|
100
|
$
|
11.325
|
OTC
|
|||||||
06/07/2023
|
B
|
500
|
$
|
11.32
|
OTC
|
|||||||
06/07/2023
|
B
|
100
|
$
|
11.32
|
OTC
|
|||||||
06/07/2023
|
B
|
200
|
$
|
11.32
|
OTC
|
|||||||
06/07/2023
|
S
|
500
|
$
|
11.32
|
NYSE
|
|||||||
06/07/2023
|
S
|
200
|
$
|
11.32
|
NYSE
|
|||||||
06/07/2023
|
S
|
100
|
$
|
11.32
|
NYSE
|
|||||||
06/07/2023
|
S
|
100
|
$
|
11.325
|
NYSE
|
|||||||
06/07/2023
|
S
|
100
|
$
|
11.32
|
NYSE
|
|||||||
06/28/2023
|
B
|
100
|
$
|
11.5
|
OTC
|
|||||||
06/28/2023
|
B
|
100
|
$
|
11.505
|
OTC
|
|||||||
06/28/2023
|
S
|
100
|
$
|
11.505
|
NYSE
|
|||||||
06/28/2023
|
S
|
100
|
$
|
11.5
|
NYSE
|
|||||||
11/07/2023
|
B
|
4,175
|
$
|
10.4166
|
OTC
|
|||||||
11/08/2023
|
S
|
4,175
|
$
|
10.4828
|
OTC
|
SWAPS | ||||||||||
TRADE DATE
|
BUY/SELL
|
QUANTITY
|
PRICE
|
EXECUTION
|
||||||
10/20/2022
|
S
|
(1)
|
(1)
|
OTC
|
||||||
10/24/2022
|
B
|
(2)
|
(2)
|
OTC
|
||||||
01/17/2023
|
S
|
(3)
|
(3)
|
OTC
|
||||||
01/18/2023
|
B
|
(4)
|
(4)
|
OTC
|
||||||
01/18/2023
|
S
|
(4)
|
(4)
|
OTC
|
||||||
01/19/2023
|
B
|
(5)
|
(5)
|
OTC
|